National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · Real-Time Price · USD
233.40
-3.35 (-1.41%)
Aug 21, 2026, 4:00 PM EDT - Market closed

National HealthCare Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
140.26120.02101.9366.822.45138.59
Depreciation & Amortization
45.7144.9241.9942.0340.4940.67
Loss (Gain) From Sale of Assets
--3.61--6.23--
Asset Writedown & Restructuring Costs
-----3.738.23
Loss (Gain) From Sale of Investments
-27.25-23.51-33.08-14.2817.13-82.38
Loss (Gain) on Equity Investments
1.330.4-0.08-1.55-0.041.2
Stock-Based Compensation
5.414.44.162.782.612.62
Other Operating Activities
13.39.0718.14.263.53-5.8
Change in Accounts Receivable
10.62-3.68-26.44-8.56-3.864.09
Change in Inventory
-0.311.24-0.6-0.31.490.2
Change in Accounts Payable
-1.27-2.736.32.24-5.53-2.08
Change in Unearned Revenue
-----24.47-42.86
Change in Other Net Operating Assets
0.9938.55-4.9824.02-41.33-0.09
Operating Cash Flow
188.81185.08107.3111.228.7462.39
Operating Cash Flow Growth
26.66%72.48%-3.52%1172.20%-85.99%-69.30%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-42.27-36.45-27.6-27.9-30.2-39.4
Sale of Property, Plant & Equipment
--2.1-4.18-
Cash Acquisitions
-54.7--213.8-2.7--
Investment in Securities
4.412.082.6213.2316.17-35.33
Other Investing Activities
-19.950.51-0.01-0.23.888.84
Investing Cash Flow
-112.51-33.86-236.69-17.57-5.98-65.89

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--150---
Long-Term Debt Repaid
--97-13.86-4.99-4.7-4.42
Net Debt Issued (Repaid)
-110-97136.14-4.99-4.7-4.42
Issuance of Common Stock
27.2114.2114.270.312.113.44
Repurchase of Common Stock
-31.91-14.73-13.5-2.48-9.9-0.84
Common Dividends Paid
-39.78-38.7-36.96-35.56-34.6-32.03
Dividends Paid
-39.78-38.7-36.96-35.56-34.6-32.03
Other Financing Activities
0.10.270.40.17-0.55-1.42
Financing Cash Flow
-154.38-135.96100.34-42.55-47.64-35.26

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-78.0815.27-29.0551.1-44.88-38.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
146.53148.6379.783.32-21.4623
Free Cash Flow Growth
23.22%86.48%-4.33%---87.32%
Free Cash Flow Margin
9.40%9.79%6.14%7.34%-2.00%2.27%
Free Cash Flow Per Share
9.309.505.115.42-1.391.49
Levered Free Cash Flow
63.17108.3851.8357.9-44.49-56.46
Unlevered Free Cash Flow
64.77112.3654.4158.1-44.14-55.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7.037.033.420.290.490.85
Cash Income Tax Paid
24.7224.7217.5314.578.7722.88
Change in Working Capital
10.0433.4-25.7217.4-73.7-40.74
SEC Filings: 10-K · 10-Q